Dr. Benjamin Kelmendi and a team of researchers at Yale University in New Haven, Connecticut, are studying the effects of MDMA on prefrontal and amygdala activation in individuals with posttraumatic stress disorder (PTSD), by fMRI. This investigator-initiated trial is currently recruiting and plans to enroll 20 participants. To learn more, visit the official study page on clinicaltrials.gov.
